Nazartinib for treatment-naive EGFR-mutant non−small cell lung cancer: Results of a phase 2, single-arm, open-label study
Titel:
Nazartinib for treatment-naive EGFR-mutant non−small cell lung cancer: Results of a phase 2, single-arm, open-label study
Auteur:
Tan, Daniel S.W. Kim, Sang-We Ponce Aix, Santiago Sequist, Lecia V. Smit, Egbert F. Yang, James C.H. Hida, Toyoaki Toyozawa, Ryo Felip, Enriqueta Wolf, Juergen Grohé, Christian Leighl, Natasha B. Riely, Gregory Cui, Xiaoming Zou, Mike Ghebremariam, Samson O'Sullivan-Djentuh, Leslie Belli, Riccardo Giovannini, Monica Kim, Dong-Wan